We provide you with 20 years of free, institutional-grade data for BMY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BMY. Explore the full financial landscape of BMY stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,721,033
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Short Bartie Wendy | Sale | -632 | $47.18 | $29,818 | 2025-09-03 |
| Short Bartie Wendy | Derivatives Exercise | 1,235 | 2025-09-03 | ||
| Elkins David V | Sale | -56,000 | $47.33 | $2,650,480 | 2025-09-03 |
| Short Bartie Wendy | Sale | -378 | $44.23 | $16,719 | 2025-08-05 |
| Short Bartie Wendy | Derivatives Exercise | 738 | 2025-08-05 | ||
| Gallman Cari | Sale | -543 | $44.23 | $24,017 | 2025-08-05 |
| Gallman Cari | Derivatives Exercise | 1,061 | 2025-08-05 | ||
| Short Bartie Wendy | Sale | -3,334 | $48.09 | $160,332 | 2025-06-04 |
| Short Bartie Wendy | Derivatives Exercise | 8,040 | 2025-06-04 | ||
| Hickey Benjamin | Sale | -97 | $38.01 | $3,687 | 2025-05-13 |
| Hirawat Samit | Open Market Purchase | 4,250 | $47.58 | 2025-04-29 | |
| Shanahan Karin | Sale | -1,692 | $59.55 | $100,759 | 2025-04-03 |
| Shanahan Karin | Derivatives Exercise | 3,306 | 2025-04-03 | ||
| Lenkowsky Adam | Sale | -6,065 | $63.11 | $382,762 | 2025-03-12 |
| Lenkowsky Adam | Derivatives Exercise | 16,684 | 2025-03-12 | ||
| Poole Ahn Amanda | Sale | -2,273 | $63.11 | $143,449 | 2025-03-12 |
| Poole Ahn Amanda | Derivatives Exercise | 7,164 | 2025-03-12 | ||
| LEUNG SANDRA | Sale | -17,710 | $63.11 | $1,117,678 | 2025-03-12 |
| LEUNG SANDRA | Derivatives Exercise | 48,718 | 2025-03-12 | ||
| Hoch Lynelle | Sale | -2,248 | $63.11 | $141,871 | 2025-03-12 |
| Hoch Lynelle | Derivatives Exercise | 7,446 | 2025-03-12 | ||
| Holzer Phil M | Sale | -1,820 | $63.11 | $114,860 | 2025-03-12 |
| Holzer Phil M | Derivatives Exercise | 7,140 | 2025-03-12 | ||
| Hirawat Samit | Sale | -16,056 | $63.11 | $1,013,294 | 2025-03-12 |
| Hirawat Samit | Derivatives Exercise | 44,098 | 2025-03-12 | ||
| Gallman Cari | Sale | -1,940 | $63.11 | $122,433 | 2025-03-12 |
| Gallman Cari | Derivatives Exercise | 7,588 | 2025-03-12 | ||
| Elkins David V | Sale | -20,935 | $63.11 | $1,321,208 | 2025-03-12 |
| Elkins David V | Derivatives Exercise | 69,517 | 2025-03-12 | ||
| BOERNER CHRISTOPHER S. | Sale | -21,797 | $63.11 | $1,375,609 | 2025-03-12 |
| BOERNER CHRISTOPHER S. | Derivatives Exercise | 60,034 | 2025-03-12 | ||
| Shanahan Karin | Sale | -7,173 | $63.11 | $452,688 | 2025-03-12 |
| Shanahan Karin | Derivatives Exercise | 20,423 | 2025-03-12 | ||
| Meyers Gregory Scott | Sale | -6,711 | $63.11 | $423,531 | 2025-03-12 |
| Meyers Gregory Scott | Derivatives Exercise | 23,150 | 2025-03-12 | ||
| Plenge Robert M | Sale | -3,610 | $63.11 | $227,827 | 2025-03-12 |
| Plenge Robert M | Derivatives Exercise | 11,255 | 2025-03-12 | ||
| Hickey Benjamin | Sale | -1,630 | $59.62 | $97,181 | 2025-03-04 |
| Hickey Benjamin | Derivatives Exercise | 3,286 | 2025-03-04 | ||
| BOERNER CHRISTOPHER S. | Open Market Purchase | 2,000 | $55.05 | 2025-02-21 | |
| Hirawat Samit | Open Market Purchase | 1,823 | $54.84 | 2025-02-19 | |
| Hickey Benjamin | Sale | -3,725 | $58.95 | $219,589 | 2025-02-04 |
| Hickey Benjamin | Derivatives Exercise | 10,078 | 2025-02-04 | ||
| Meyers Gregory Scott | Sale | -833 | $58.95 | $49,105 | 2025-02-04 |
| Meyers Gregory Scott | Derivatives Exercise | 2,543 | 2025-02-04 | ||
| Hirawat Samit | Open Market Purchase | 1,830 | $54.67 | 2024-11-05 | |
| Holzer Phil M | Sale | -700 | $55.62 | $38,931 | 2024-11-05 |
| BOERNER CHRISTOPHER S. | Sale | -1,488 | $54.32 | $80,828 | 2024-11-05 |
| BOERNER CHRISTOPHER S. | Derivatives Exercise | 2,964 | 2024-11-05 | ||
| Gallman Cari | Sale | -1,648 | $53.76 | $88,596 | 2024-10-03 |
| Gallman Cari | Derivatives Exercise | 4,558 | 2024-10-03 | ||
| Gallman Cari | Sale | -384 | $48.17 | $18,497 | 2024-08-05 |
| Gallman Cari | Derivatives Exercise | 1,061 | 2024-08-05 | ||
| Shanahan Karin | Sale | -1,196 | $52.99 | $63,376 | 2024-04-02 |
| Shanahan Karin | Derivatives Exercise | 3,306 | 2024-04-02 | ||
| Hirawat Samit | Sale | -13,649 | $53.79 | $734,180 | 2024-03-12 |
| Hirawat Samit | Derivatives Exercise | 38,388 | 2024-03-12 | ||
| Hoch Lynelle | Sale | -1,308 | $53.79 | $70,357 | 2024-03-12 |
| Hoch Lynelle | Derivatives Exercise | 4,351 | 2024-03-12 | ||
| Holzer Phil M | Sale | -1,389 | $53.79 | $74,714 | 2024-03-12 |
| Holzer Phil M | Derivatives Exercise | 5,520 | 2024-03-12 | ||
| Gallman Cari | Sale | -696 | $53.79 | $37,438 | 2024-03-12 |
| Gallman Cari | Derivatives Exercise | 2,761 | 2024-03-12 | ||
| BOERNER CHRISTOPHER S. | Sale | -19,407 | $53.79 | $1,043,903 | 2024-03-12 |
| BOERNER CHRISTOPHER S. | Derivatives Exercise | 54,638 | 2024-03-12 | ||
| Caforio Giovanni | Sale | -67,823 | $53.79 | $3,648,199 | 2024-03-12 |
| Caforio Giovanni | Derivatives Exercise | 190,130 | 2024-03-12 | ||
| Elkins David V | Sale | -18,522 | $53.79 | $996,298 | 2024-03-12 |
| Elkins David V | Derivatives Exercise | 64,326 | 2024-03-12 | ||
| Lenkowsky Adam | Sale | -4,323 | $53.79 | $232,534 | 2024-03-12 |
| Lenkowsky Adam | Derivatives Exercise | 15,016 | 2024-03-12 | ||
| Poole Ahn Amanda | Sale | -1,375 | $53.79 | $73,961 | 2024-03-12 |
| Poole Ahn Amanda | Derivatives Exercise | 5,458 | 2024-03-12 | ||
| Plenge Robert M | Sale | -1,965 | $53.79 | $105,697 | 2024-03-12 |
| Plenge Robert M | Derivatives Exercise | 9,143 | 2024-03-12 | ||
| LEUNG SANDRA | Sale | -16,660 | $53.79 | $896,141 | 2024-03-12 |
| LEUNG SANDRA | Derivatives Exercise | 46,784 | 2024-03-12 | ||
| Hickey Benjamin | Initial | 2024-03-04 | |||
| Holzer Phil M | Initial | 2024-02-23 | |||
| Meyers Gregory Scott | Sale | -754 | $48.67 | $36,697 | 2024-02-05 |
| Meyers Gregory Scott | Derivatives Exercise | 2,543 | 2024-02-05 |
The information provided in this report about BMY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bristol-Myers Squibb Company(NYSE:BMY) 
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the tr...
Website: http://www.bms.com
Founded: 1887
Full Time Employees: 30,000
Sector: Healthcare
Industry: Drug Manufacturers-General